# Slide Insurance Holdings, Inc.: financial statements, quarterly

SLDE · Nasdaq · CIK 1886428 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slde.md) · [Financials](/companies/slde/financials.md) · [Filings](/companies/slde/filings.md) · [Insiders](/companies/slde/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slde/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [209](/filings/0000950170-25-107317.md) | [200](/filings/0001193125-25-267339.md) | [238 d](/filings/0001193125-26-083277.md) | [282](/filings/0001193125-26-197194.md) | [262](/filings/0001193125-26-326333.md) | [266](/filings/0001193125-25-267339.md) | [347 d](/filings/0001193125-26-083277.md) | [389](/filings/0001193125-26-197194.md) | [387](/filings/0001193125-26-326333.md) |
| Income tax | $m | [17.7](/filings/0000950170-25-107317.md) | [6.8](/filings/0001193125-25-267339.md) | [25.7 d](/filings/0001193125-26-083277.md) | [31.4](/filings/0001193125-26-197194.md) | [26.2](/filings/0001193125-26-326333.md) | [36.0](/filings/0001193125-25-267339.md) | [51.6 d](/filings/0001193125-26-083277.md) | [46.1](/filings/0001193125-26-197194.md) | [43.6](/filings/0001193125-26-326333.md) |
| Net income | $m | [53.7](/filings/0000950170-25-107317.md) | [17.6](/filings/0001193125-25-267339.md) | [75.1 d](/filings/0001193125-26-083277.md) | [92.5](/filings/0001193125-26-197194.md) | [70.1](/filings/0001193125-26-326333.md) | [111](/filings/0001193125-25-267339.md) | [170 d](/filings/0001193125-26-083277.md) | [140](/filings/0001193125-26-197194.md) | [135](/filings/0001193125-26-326333.md) |
| Diluted EPS | $ per share | [0.45](/filings/0000950170-25-107317.md) | [0.15](/filings/0001193125-25-267339.md) | not reported | [0.75](/filings/0001193125-26-197194.md) | [0.56](/filings/0001193125-26-326333.md) | [0.79](/filings/0001193125-25-267339.md) | not reported | [1.02](/filings/0001193125-26-197194.md) | [1.06](/filings/0001193125-26-326333.md) |
| Basic EPS | $ per share | [0.96](/filings/0000950170-25-107317.md) | [0.31](/filings/0001193125-25-267339.md) | not reported | [1.63](/filings/0001193125-26-197194.md) | [1.05](/filings/0001193125-26-326333.md) | [0.89](/filings/0001193125-25-267339.md) | not reported | [1.13](/filings/0001193125-26-197194.md) | [1.17](/filings/0001193125-26-326333.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [493](/filings/0001193125-26-083277.md) | not reported | [936](/filings/0000950170-25-107317.md) | [862](/filings/0001193125-25-267339.md) | [1,201](/filings/0001193125-26-326333.md) | [1,218](/filings/0001193125-26-197194.md) | [1,237](/filings/0001193125-26-326333.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [1,932](/filings/0001193125-26-083277.md) | not reported | [2,814](/filings/0000950170-25-107317.md) | [2,687](/filings/0001193125-25-267339.md) | [2,918](/filings/0001193125-26-326333.md) | [2,882](/filings/0001193125-26-197194.md) | [3,599](/filings/0001193125-26-326333.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [1,499](/filings/0001193125-26-083277.md) | not reported | [1,946](/filings/0000950170-25-107317.md) | [1,723](/filings/0001193125-25-267339.md) | [1,805](/filings/0001193125-26-326333.md) | [1,769](/filings/0001193125-26-197194.md) | [2,404](/filings/0001193125-26-326333.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [39.2](/filings/0001193125-26-083277.md) | not reported | [36.3](/filings/0000950170-25-107317.md) | [35.0](/filings/0001193125-25-267339.md) | [33.7](/filings/0001193125-26-326333.md) | [32.4](/filings/0001193125-26-197194.md) | [29.7](/filings/0001193125-26-326333.md) |
| Shareholders' equity | $m | [238](/filings/0001193125-26-083277.md) | [291](/filings/0000950170-25-107317.md) | [344](/filings/0001193125-25-267339.md) | [369](/filings/0001193125-25-267339.md) | [433](/filings/0001193125-26-083277.md) | [532](/filings/0001193125-26-326333.md) | [868](/filings/0000950170-25-107317.md) | [964](/filings/0001193125-25-267339.md) | [1,113](/filings/0001193125-26-326333.md) | [1,114](/filings/0001193125-26-197194.md) | [1,195](/filings/0001193125-26-326333.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [120 d](/filings/0001193125-25-267339.md) | [158 d](/filings/0001193125-26-083277.md) | [96.8](/filings/0001193125-26-197194.md) | [254 d](/filings/0001193125-26-326333.md) | [25.3 d](/filings/0001193125-25-267339.md) | [422 d](/filings/0001193125-26-083277.md) | [289](/filings/0001193125-26-197194.md) | [301 d](/filings/0001193125-26-326333.md) |
| Capital expenditure | $m | [5.1 d](/filings/0001193125-25-267339.md) | [0.8 d](/filings/0001193125-26-083277.md) | [0.6](/filings/0001193125-26-197194.md) | [0.9 d](/filings/0001193125-26-326333.md) | [0.8 d](/filings/0001193125-25-267339.md) | [0.5 d](/filings/0001193125-26-083277.md) | [0.7](/filings/0001193125-26-197194.md) | [0.4 d](/filings/0001193125-26-326333.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001193125-26-083277.md) | [0.0](/filings/0001193125-26-197194.md) | [0.0 d](/filings/0001193125-26-326333.md) | [20.0 d](/filings/0001193125-25-267339.md) | [20.0 d](/filings/0001193125-26-083277.md) | [137](/filings/0001193125-26-197194.md) | [53.8 d](/filings/0001193125-26-326333.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [56.2](/filings/0000950170-25-107317.md) | [120](/filings/0001193125-25-267339.md) | [123](/filings/0001193125-26-197194.md) | [126](/filings/0001193125-26-326333.md) | [140](/filings/0001193125-25-267339.md) | [137](/filings/0001193125-26-197194.md) | [127](/filings/0001193125-26-326333.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 116,811,719 at 2026-07-30, from the cover of the [10-Q filed 2026-07-30](/filings/0001193125-26-326333.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.